Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 352

1.

Self-monitoring of blood glucose.

Garg S, Hirsch IB.

Int J Clin Pract Suppl. 2010 Feb;(166):1-10. doi: 10.1111/j.1742-1241.2009.02271.x. Review.

PMID:
20377657
2.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
3.

Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria.

Schütt M, Kern W, Krause U, Busch P, Dapp A, Grziwotz R, Mayer I, Rosenbauer J, Wagner C, Zimmermann A, Kerner W, Holl RW; DPV Initiative..

Exp Clin Endocrinol Diabetes. 2006 Jul;114(7):384-8.

PMID:
16915542
4.

Diabetes technology and treatments in the paediatric age group.

Shalitin S, Peter Chase H.

Int J Clin Pract Suppl. 2011 Feb;(170):76-82. doi: 10.1111/j.1742-1241.2010.02582.x. Review.

PMID:
21323816
5.

Oral antidiabetic agents: current role in type 2 diabetes mellitus.

Krentz AJ, Bailey CJ.

Drugs. 2005;65(3):385-411. Review.

PMID:
15669880
6.

The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies.

Franciosi M, Pellegrini F, De Berardis G, Belfiglio M, Cavaliere D, Di Nardo B, Greenfield S, Kaplan SH, Sacco M, Tognoni G, Valentini M, Nicolucci A; QuED Study Group..

Diabetes Care. 2001 Nov;24(11):1870-7.

PMID:
11679449
7.
8.

Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study.

Martin S, Schneider B, Heinemann L, Lodwig V, Kurth HJ, Kolb H, Scherbaum WA.

Diabetologia. 2006 Feb;49(2):271-8.

PMID:
16362814
9.

Self-monitoring of blood glucose in diabetes: is it worth it?

O'Kane MJ, Pickup J.

Ann Clin Biochem. 2009 Jul;46(Pt 4):273-82. doi: 10.1258/acb.2009.009011. Review.

PMID:
19454538
11.

Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial.

Garg S, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, Jovanovic L.

Diabetes Care. 2006 Jan;29(1):44-50.

PMID:
16373894
12.
14.

Self-monitoring of blood glucose in people with type 1 and type 2 diabetes living in France: the Entred study 2001.

Lecomte P, Romon I, Fosse S, Simon D, Fagot-Campagna A.

Diabetes Metab. 2008 Jun;34(3):219-26. doi: 10.1016/j.diabet.2007.11.005.

15.

Use of continuous glucose monitoring in patients with type 1 diabetes.

Ellis SL, Naik RG, Gemperline K, Garg SK.

Curr Diabetes Rev. 2008 Aug;4(3):207-17. Review.

PMID:
18690902
16.

Effects of health maintenance organization coverage of self-monitoring devices on diabetes self-care and glycemic control.

Soumerai SB, Mah C, Zhang F, Adams A, Barton M, Fajtova V, Ross-Degnan D.

Arch Intern Med. 2004 Mar 22;164(6):645-52.

PMID:
15037493
17.

Self-monitoring of blood glucose in non-insulin treated patients with type 2 diabetes: a systematic review and meta-analysis.

Allemann S, Houriet C, Diem P, Stettler C.

Curr Med Res Opin. 2009 Dec;25(12):2903-13. doi: 10.1185/03007990903364665. Review.

PMID:
19827909
19.

Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).

Abraira C, Henderson WG, Colwell JA, Nuttall FQ, Comstock JP, Emanuele NV, Levin SR, Sawin CT, Silbert CK.

Diabetes Care. 1998 Apr;21(4):574-9.

PMID:
9571345
20.

Insulin therapy in type 2 diabetes.

Mudaliar S, Edelman SV.

Endocrinol Metab Clin North Am. 2001 Dec;30(4):935-82. Review.

PMID:
11727406
Items per page

Supplemental Content

Support Center